Ventas cuts target price to $91 from $102
VTR•Barclays cut its target price for Ventas to $91 from $102.
Related News
Scinai expands CDMO business with $5.1 million development and clinical manufacturing agreement
SCNI•
Origin Agritech receives full $2.8 million from private placement of 2 million shares at $1.40 each
SEED•
U.S. stocks on the move: Johnson & Johnson, JPMorgan, UnitedHealth, Goldman Sachs
SPY•
Opus Genetics presents at Chardan Annual Healthcare Conference
IRD•
Scaleway to build AMD-powered AI supercomputer in Sweden
AMD•